N/A
Completed N=111
Clinical Performance of Two Commercial, Daily Disposable Contact Lenses
Source: ClinicalTrials.gov NCT05010512 ↗Enrolled (actual)
111
Serious AEs
0.0%
Results posted
Nov 2022
Primary outcomePrimary: Least Squares Mean Distance VA (logMAR) With Study Lenses — -0.10; -0.10 logMAR
Summary
The purpose of this study is to compare the clinical performance of DAILIES TOTAL1 ( DT1) contact lenses with Infuse contact lenses.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Least Squares Mean Distance VA (logMAR) With Study Lenses |
-0.10; -0.10 | — |
Eligibility Criteria
Key Inclusion Criteria
- Habitually wears soft contact lenses in both eyes at least 5 days per week and at least 10 hours per day;
- At least 3 months of contact lens wearing experience;
- Less than or equal to 0.75 diopter (D) astigmatism in each eye;
- Best Corrected Visual Acuity (BCVA) better than or equal to 20/25 in each eye.
- Other protocol-defined inclusion criteria may apply.
Key Exclusion Criteria
- Current/previous DAILIES TOTAL1 and/or Infuse habitual lens wearer;
- Monovision and/or multifocal lens wearer;
- Routinely sleeps in habitual contact lenses.
- Other protocol-defined exclusion criteria may apply.
Data sourced from ClinicalTrials.gov (NCT05010512). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.